Cargando…

The Good, the Bad and the New about Uric Acid in Cancer

SIMPLE SUMMARY: The concentration of uric acid in blood is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant and is...

Descripción completa

Detalles Bibliográficos
Autores principales: Allegrini, Simone, Garcia-Gil, Mercedes, Pesi, Rossana, Camici, Marcella, Tozzi, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561999/
https://www.ncbi.nlm.nih.gov/pubmed/36230882
http://dx.doi.org/10.3390/cancers14194959
_version_ 1784808073103147008
author Allegrini, Simone
Garcia-Gil, Mercedes
Pesi, Rossana
Camici, Marcella
Tozzi, Maria Grazia
author_facet Allegrini, Simone
Garcia-Gil, Mercedes
Pesi, Rossana
Camici, Marcella
Tozzi, Maria Grazia
author_sort Allegrini, Simone
collection PubMed
description SIMPLE SUMMARY: The concentration of uric acid in blood is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant and is a scavenger of singlet oxygen and radicals. At high intracellular concentration, uric acid has been demonstrated to act as a pro-oxidant molecule. Recently, uric acid has been reported to affect the properties of several proteins involved in metabolic regulation and signaling, and the relationship between uric acid and cancer has been extensively investigated. In this review, we present the most recent results on the positive and negative effects played by uric acid in cancer and some new findings and hypotheses about the implication of this metabolite in the pathogenesis of several diseases such as metabolic syndrome, diabetes, and inflammation, thus favoring the development of cancer. ABSTRACT: Uric acid is the final product of purine catabolism in man and apes. The serum concentration of uric acid is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant, while at high intracellular concentrations, it is a pro-oxidant molecule. In this review, we describe the possible causes of uric acid accumulation or depletion and some of the metabolic and regulatory pathways it may impact. Particular attention has been given to fructose, which, because of the complex correlation between carbohydrate and nucleotide metabolism, causes uric acid accumulation. We also present recent results on the positive and negative effects played by uric acid in cancer and some new findings and hypotheses about the implication of this metabolite in a variety of signaling pathways, which can play a role in the pathogenesis of diseases such as metabolic syndrome, diabetes, and inflammation, thus favoring the development of cancer. The loss of uricase in Homo sapiens and great apes, although exposing these species to the potentially adverse effects of uric acid, appears to be associated with evolutionary advantages.
format Online
Article
Text
id pubmed-9561999
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95619992022-10-15 The Good, the Bad and the New about Uric Acid in Cancer Allegrini, Simone Garcia-Gil, Mercedes Pesi, Rossana Camici, Marcella Tozzi, Maria Grazia Cancers (Basel) Review SIMPLE SUMMARY: The concentration of uric acid in blood is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant and is a scavenger of singlet oxygen and radicals. At high intracellular concentration, uric acid has been demonstrated to act as a pro-oxidant molecule. Recently, uric acid has been reported to affect the properties of several proteins involved in metabolic regulation and signaling, and the relationship between uric acid and cancer has been extensively investigated. In this review, we present the most recent results on the positive and negative effects played by uric acid in cancer and some new findings and hypotheses about the implication of this metabolite in the pathogenesis of several diseases such as metabolic syndrome, diabetes, and inflammation, thus favoring the development of cancer. ABSTRACT: Uric acid is the final product of purine catabolism in man and apes. The serum concentration of uric acid is sex-, age- and diet-dependent and is maintained close to its maximal solubility, indicating that it plays some important role. Indeed, it has been demonstrated that, at physiological concentrations, uric acid is a powerful antioxidant, while at high intracellular concentrations, it is a pro-oxidant molecule. In this review, we describe the possible causes of uric acid accumulation or depletion and some of the metabolic and regulatory pathways it may impact. Particular attention has been given to fructose, which, because of the complex correlation between carbohydrate and nucleotide metabolism, causes uric acid accumulation. We also present recent results on the positive and negative effects played by uric acid in cancer and some new findings and hypotheses about the implication of this metabolite in a variety of signaling pathways, which can play a role in the pathogenesis of diseases such as metabolic syndrome, diabetes, and inflammation, thus favoring the development of cancer. The loss of uricase in Homo sapiens and great apes, although exposing these species to the potentially adverse effects of uric acid, appears to be associated with evolutionary advantages. MDPI 2022-10-10 /pmc/articles/PMC9561999/ /pubmed/36230882 http://dx.doi.org/10.3390/cancers14194959 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Allegrini, Simone
Garcia-Gil, Mercedes
Pesi, Rossana
Camici, Marcella
Tozzi, Maria Grazia
The Good, the Bad and the New about Uric Acid in Cancer
title The Good, the Bad and the New about Uric Acid in Cancer
title_full The Good, the Bad and the New about Uric Acid in Cancer
title_fullStr The Good, the Bad and the New about Uric Acid in Cancer
title_full_unstemmed The Good, the Bad and the New about Uric Acid in Cancer
title_short The Good, the Bad and the New about Uric Acid in Cancer
title_sort good, the bad and the new about uric acid in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561999/
https://www.ncbi.nlm.nih.gov/pubmed/36230882
http://dx.doi.org/10.3390/cancers14194959
work_keys_str_mv AT allegrinisimone thegoodthebadandthenewabouturicacidincancer
AT garciagilmercedes thegoodthebadandthenewabouturicacidincancer
AT pesirossana thegoodthebadandthenewabouturicacidincancer
AT camicimarcella thegoodthebadandthenewabouturicacidincancer
AT tozzimariagrazia thegoodthebadandthenewabouturicacidincancer
AT allegrinisimone goodthebadandthenewabouturicacidincancer
AT garciagilmercedes goodthebadandthenewabouturicacidincancer
AT pesirossana goodthebadandthenewabouturicacidincancer
AT camicimarcella goodthebadandthenewabouturicacidincancer
AT tozzimariagrazia goodthebadandthenewabouturicacidincancer